title: Continuous positive air pressure treatment reduces serum advanced glycation end products in patients with obstructive sleep apnoea syndrome: a pilot study.
abstract: Nasal continuous positive air pressure (nCPAP) treatment may favourably affect serum levels of advanced glycation end products (AGEs) in patients with obstructive sleep apnoea syndrome (OSAS). At baseline, OSAS patients had significantly higher levels of AGEs than controls. Six months after nCPAP initiation, AGEs decreased significantly. nCPAP treatment could lower AGEs in patients with OSAS.
authors: Division of Preventive Medicine, Clinical Research Institute for Endocrine and Metabolic Disease, National Hospital Organization Kyoto Medical Center, Kyoto, Japan. kazukotani@jichi.ac.jp
authors: Kazuhiko
authors: K
authors: Kotani
authors: Satoshi
authors: S
authors: Kimura
authors: Ichiro
authors: I
authors: Komada
authors: Naoki
authors: N
authors: Sakane
authors: Alejandro
authors: A
authors: Gugliucci
mesh_terms: D005260:Female; D017127:Glycation End Products, Advanced / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011175:Positive-Pressure Respiration; D020181:Sleep Apnea, Obstructive / Q000097:blood*
chemical_list: D017127:Glycation End Products, Advanced